Culturally Adapted Cognitive Behavior Therapy for Individuals At Risk of First Episode Psychosis
1 other identifier
interventional
90
1 country
2
Brief Summary
Young people constitute nearly half of Pakistan's population and are highly vulnerable to risk factors for mental illness, including poverty, inequality, abuse, and violence. Estimates suggest that 19-34% of children and adolescents experience emotional or behavioural disorders, though this is likely underestimated. In recent years, research has focused on those at imminent risk of developing serious conditions such as first episode psychosis. The concept of an At-Risk Mental State (ARMS) has highlighted the urgent need for interventions that address current symptoms, improve functioning, and reduce transition to psychosis. Up to 80% of young people with ARMS have another diagnosable condition, and almost half show poor psychosocial outcomes even six years after initial help-seeking. Evidence demonstrates that early identification and treatment can delay or prevent psychosis, including severe and enduring illnesses like schizophrenia. Cognitive Behaviour Therapy (CBT) is among the most effective evidence-based approaches for this group. However, existing evidence comes largely from high-income countries, raising concerns about cultural applicability in low-resource settings. This study will culturally adapt and field test a manualised CBT intervention for young people at risk of first episode psychosis. To our knowledge, this is the first such study in a low-income country. Findings will inform scalable, culturally relevant interventions for Pakistan and similar contexts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
April 13, 2026
April 1, 2026
1.5 years
September 16, 2025
April 6, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility Indicator
feasibility will be determined by collecting data on recruitment and retention rates, The success criterion of feasibility will be to recruit \> 50% of eligible participants
From baseline to 12th week (end of intervention)
Acceptability Indicator
Intervention acceptability will be assessed using data on attendance. Criterion for acceptability is a mean attendance rate of \>70%.
From baseline to 12th week (end of intervention)
Other Outcomes (9)
The Prodromal Questionnaire
From baseline to 12th week (end of intervention)
Brief-Comprehensive Assessment of At-Risk Mental States
From baseline to 12th week (end of intervention)
Client Satisfaction Questionnaire
From baseline to 12th week (end of intervention)
- +6 more other outcomes
Study Arms (2)
Cognitive Behavior Therapy for those at risk of first episode psychosis
EXPERIMENTALThe participants in the intervention group will receive a culturally adapted manualised cognitive behavioral therapy (CBT). The interventions aim to reduce symptoms, normalises psychosis-like experiences and prevents a catastrophic appraisal of the psychotic-like symptoms from occurring
Treatment as Usual
NO INTERVENTIONTreatment As Usual (TAU): Local medical, psychiatric and primary care services provide standard routine care according to their clinical judgment and available resources. These participants will receive an initial assessment along with TAU as ascertained by their treating doctor at the hospital. In current practice, individuals with ARMS (at risk of first episode psychosis) are not routinely referred to any psychological service in Pakistan. TAU in Pakistan largely comprises of pharmacotherapy. Research staff will record the nature and intensity of the routine care delivered for each participant.
Interventions
Participants will receive a culturally adapted manualised Cognitive Behavioural Therapy (CBT) for those at risk of first episode psychosis (FEP). The intervention aims to reduce symptoms, normalise psychosis-like experiences, and prevent catastrophic appraisals that may lead to delusions. It integrates psychoeducation, behavioural experiments, and techniques addressing cognitive biases. By reframing unusual experiences as perceptual or reasoning biases, distress and emotional arousal are reduced, lowering the chance of fixed, frightening beliefs. Homework tasks further support coping. CBT for At-Risk Mental States has shown effectiveness in reducing transition to psychosis and improving recovery. This study will adapt and field test the manual, with potential for remote delivery via phone, video, or AI tools to enhance accessibility.
Eligibility Criteria
You may qualify if:
- Male or female help-seeking individual aged 16-35 years;
- Score 6 or above on PQ-16
- Meet the at risk of FEP criteria using CAARMS Operationalized Intake Criteria based on three groups (vulnerability, attenuated psychosis or brief limited intermittent psychotic symptoms group);
- Assessed as competent to provide informed consent.
- Give written informed consent.
You may not qualify if:
- Temporary resident unlikely to be available for follow up.
- Unable to engage, participate or respond to research questionnaires.
- a history of psychotic illness (treated or untreated).
- previous treatment with an antipsychotic or mood-stabilising agent.
- active substance abuse (except nicotine or caffeine) or dependence within the last three months, according to DSM-V criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Commuity/Schools/Colleges
Karachi, Sindh, Pakistan
Karwan e Hayat
Karachi, Sindh, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ameer B Khoso, PhD
Pakistan Institute of Living and Learning
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Researchers conducting outcome assessments will be blind to treatment allocations
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2025
First Posted
September 23, 2025
Study Start
January 1, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04